Collateral for a security interest recorded Feb 13, 2025 (Malin Life Sciences (US), Inc.).
Term ends Jun 8, 2031 · Low confidence
20-year base term ends Jun 8, 2031
Held by Xenex Disinfection Services Inc.
Filed Mar 18, 2015 as application 14/661,089 · Granted Jul 4, 2017
Base term, 20 years from filing
Today
2011
2031
Clock starts
Jun 8, 2011
Jun 8, 2011
Term ends
Jun 8, 2031
Jun 8, 2031
Granted
Jul 4, 2017
Jul 4, 2017
base term
fee events
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,165,756, to Jun 8, 2031. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
15
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 8, 2011, when application 13/156,131, the earliest non-provisional in its chain, was filed (this one was filed Mar 18, 2015); a parent in its chain could not be resolved (the next row) | Jun 8, 2031 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,165,756) | resolves to Jun 8, 2031, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: 13156131 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Jun 8, 2031 | Low confidence |
This family
| US 9,165,756 | Lapsed on the fee record Oct 2023 | Oct 2023 |
| Application PCT/US2012/041483 | PCT application no patent term | no patent term |
| US 9,744,255 | In force Aug 2033 | Aug 2033 |
| Application PCT/US2012/068216 | PCT application no patent term | no patent term |
| US 9,698,003 | this patent Jun 2031 | Jun 2031 |
| US 10,410,853 | In force Jun 2031 | Jun 2031 |
| US 10,772,980 | In force Jun 2031 | Jun 2031 |
| US 11,929,247 | In force Jun 2031 | Jun 2031 |
8 of 15 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 18, 2015 Reel 35188, frame 937 | Stibich, Mark Andrew; Wolford, James Blaine; Garfield, Alexander Nathan; Rathgeber, Martin; Frydendall, Eric Martin | Xenex Healthcare Services, LLC | Assignment of Assignor's Interest |
| Mar 18, 2015 Reel 35222, frame 596 | Xenex Healthcare Services, LLC | Xenex Disinfection Services, LLC | Change of Name |
| Jan 28, 2016 Reel 37605, frame 753 | Xenex Disinfection Services LLC | Comerica Bank | Security Interest |
| Oct 18, 2019 Reel 50767, frame 431 | Xenex Disinfection Services LLC. | Xenex Disinfection Services Inc. | Change of Name |
| Dec 4, 2020 Reel 54546, frame 404 | Comerica Bank | Xenex Disinfection Services, Inc. | Release of Security Interest |
| Jan 19, 2021 Reel 54952, frame 7 | Comerica Bank | Xenex Disinfection Services, Inc. | Release of Security Interest |
| Feb 13, 2025 Reel 70629, frame 867 | Xenex Disinfection Services Inc. | Malin Life Sciences (US), Inc. | Security Interest |
| Mar 2, 2026 Reel 75060, frame 415 | Malin Life Sciences (US), Inc. | Malin Life Sciences Holdings Limited | Assignment and Assumption of Security Agreement, IP Security Agreement and Collateral Agent Agreement |
| May 26, 2026 Reel 75626, frame 146 | Malin Life Sciences Holdings Limited | XDS Collateral, LLC | Assignment and Assumption of Security Agreement, IP Security Agreement and Collateral Agent Agreement |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jun 2031
Term ends Jun 8, 2031. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 9,165,756, ends no earlier than this term, so it caps nothing.
Citations
20
later US patents cite this one
That is top 25% of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.